GSK-COR111096

Study Sponsor: GSK

Study Title

COR111096, A Randomized, Double-Blind, Active-Controlled, Parallel Group, Multicenter Study Comparing the Proportion of Subjects with Stage 1 or 2 Essential Hypertension Who Achieve Target Blood Pressure While Receiving Either carvedilol CR + lisinopril or lisinopril Monotherapy

Medicine or Vaccine (generic name)

carvedilol

Sponsor Identification Number

COR111096

Trial Registry Identification Number(#'s)

NCT00624065

Medical Condition

Hypertension

Phase

Phase 3

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=COR111096

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT00624065

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

May 2013